Low-dose Hormone Therapy for Relief of Vasomotor Symptoms

Completed · Phase 3 · Has a placebo group

Conditions studied: Vasomotor Symptoms, Hot Flashes

In brief

The purpose of this study is to determine the lowest effective dose of the study drug for the relief of moderate to severe vasomotor symptoms in postmenopausal women for 12 weeks.

Key facts

Study ID
NCT00446199
Run by
Bayer
People needed
735
Starts
2007-03-01
Expected to finish
2008-11-01
Last updated by the study team
2015-05-06

Who can join

Age: 40 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.